Wire Stories

Category Added in a WPeMatico Campaign

news_6

Heartseed and ITOCHU CHEMICAL FRONTIER Sign Capital Alliance Agreement to Explore iPSC and Cardiomyocyte Business Opportunities

TOKYO--(BUSINESS WIRE)--#biotech--Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), today...

news_6

Technologies Developed by the Ministry-led Open Innovation Activity Are Now Open to Discuss for Possible Future International Collaboration.

TOKYO--(BUSINESS WIRE)--MAFF has just published the “Technology List” covering the novel technologies developed under the Ministry-led open innovation activity named...